Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

High Risk for Febrile Neutropenia of Chemotherapy Regimens

Tundra lists 1 High Risk for Febrile Neutropenia of Chemotherapy Regimens clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT07187908

Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropenia (FN) or Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in FN

Efbemalenograstim alfa for primary/secondary prevention in patients with solid tumors at high risk for febrile neutropenia (FN) or Intermediate risk of chemotherapy regimens associated with other risk factors in FN

Gender: All

Ages: 18 Years - 75 Years

Updated: 2025-09-23

1 state

Primary/Secondary Prevention

High Risk for Febrile Neutropenia of Chemotherapy Regimens

Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in Febrile Neutropenia